Pyx Health: Revolutionizing Healthcare with a Strategic Investment from TT Capital Partners
Gracie Gottlieb | 20 July, 2023
For Immediate Release MINNEAPOLIS -- Pyx Health, a leading tech-enabled services company, has announced a major growth investment from TT Capital Partners (TTCP). This strategic partnership will fuel Pyx Health's expansion plans and help to address the growing issue of loneliness and social isolation in vulnerable populations. Loneliness and social determinants of health have become significant concerns in recent years, with healthcare providers recognizing their impact on patient outcomes and healthcare costs. Pyx Health's innovative app-based technology, combined with personalized human interventions, offers a scalable solution that effectively reduces loneliness and improves overall health and wellbeing. Founded in 2017, Pyx Health has quickly established itself as a trusted provider, serving over 6 million covered lives across more than 70 markets in nearly 30 states. The company collaborates with major payers, government agencies, employers, and community health plans throughout the United States. TT Capital Partners is a value-add healthcare investor specializing in healthcare technology and services companies. They bring not only capital but also extensive industry expertise and a vast network of healthcare professionals to support the growth of Pyx Health. TTCP's investment will help raise the profile of Pyx Health and enhance its ability to tackle loneliness and social determinants of health on a larger scale. Cindy Jordan, Founder and CEO of Pyx Health, was inspired to create the company based on her stepdaughter's personal struggle with loneliness. Recognizing loneliness as a public health crisis, Jordan developed a non-clinical, science-based solution that fills the gaps in traditional healthcare systems. Pyx Health's approach combines data-driven insights, technology, and compassionate peer-to-peer support to effectively combat loneliness and improve mental health outcomes. The partnership between Pyx Health and TT Capital Partners is a natural fit, as both organizations share a commitment to improving health equity and consumer engagement. TTCP's deep healthcare expertise and extensive connections within the industry will help Pyx Health expand its reach and impact. Adam Letson, Principal at TTCP, expressed their enthusiasm for the partnership, stating that they are eager to provide operational support as Pyx Health continues to scale. TTCP has a successful history of partnering with engagement and services businesses that cater to underserved individuals within the healthcare system. The financial terms of the investment were not disclosed. TripleTree LLC served as the exclusive financial advisor to Pyx Health, while Weiss Brown PLLC and Brownstein Hyatt Farber Schreck LLP provided legal advice to the company. Bass, Berry & Sims PLC acted as legal advisors to TTCP. About Pyx Health Pyx Health is a leading provider of evidence-based, data-driven solutions for loneliness. By leveraging scalable technology and compassionate peer-to-peer support, Pyx Health effectively addresses the critical issue of loneliness and its impact on mental and physical health. The company's innovative approach improves patient outcomes, reduces healthcare costs, and helps individuals connect with others in meaningful ways. To learn more about Pyx Health and its mission to combat loneliness, visit their website at www.pyxhealth.com, and follow them on LinkedIn, Twitter, and Facebook. About TT Capital Partners TT Capital Partners (TTCP) is a healthcare-focused investment firm that provides capital, expertise, and insight to healthcare technology and services companies. With a keen understanding of the healthcare industry and a vast network of connections, TTCP invests in high-growth businesses that are transforming the delivery, management, and consumption of healthcare. For more information about TT Capital Partners and their investment philosophy, visit their website at www.TTCapitalPartners.com.
[Note: The press release has been modified and paraphrased to create a unique and original article. The content of the article is based on public information and does not include any confidential or proprietary details.]
Other Posts
- Blue Fin Capital, Inc. Q2 2023 vs. Q3 2023: A Deep Dive into the 13F Holdings Comparison
- Investment Giant Geode Capital Management's Q3 2022 vs. Q4 2022 Stock Portfolio Analysis
- Investment Portfolio Changes: Prime Capital Advisors Holdings Q4 2022 vs. Q1 2023
- Donaldson Capital Management, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Investment Insights: WealthShield Partners, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Navigating Market Tides: Radnor Capital's Strategic Moves in Equities from Q4 2023 to Q1 2024
- Investment Strategy Comparison of Strategic Wealth Partners Group LLC Q3 2022 and Q4 2022
- Navigating the Winds of Change: Insights into Cohen Klingenstein LLC's Investment Moves
- The Evolving Landscape: Comparing Lisanti Capital's Q3 and Q4 2022 Holdings
- Retirement Planning Group, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison